← Leaderboards
Jeffrey A. Mattis
Molecular Targeting Technology, Inc.
$1,142,571
Attributed
$1,142,571
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $418.8K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,142,571 · 2
By mechanism
U01$917,752 · 1
R43$224,819 · 1
Top collaborators
No co-investigators on record.
Most similar at Molecular Targeting Technology, Inc.
Same institution · by research overlap
- Koon Y Pak$3,938,172
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationMonoclonal AntibodyImmunologic Substance Development /PreparationBioterrorism /Chemical WarfareLaboratory MouseDisease /Disorder Prevention /ControlPassive ImmunizationNonhuman Therapy EvaluationSaimiriRabiesVaccine DevelopmentHamstersCooperative StudyRabies VaccinesCardiotoxicityCardiacAntitumor AgentCancer TherapyCancer PatientAntineoplastic AgentsAffinityClinical PracticeClinical TrialsClinically Significant
Grant awards (4)
A PE-specific SPECT probe for the early detection of cancer treatment-induced cardiotoxicity.$224,819
R43 · FY2015 · HL · contact PI
Human Mab cocktail for rabies post-exposure prophylaxis$418,825
U01 · FY2005 · AI
Human Mab cocktail for rabies post-exposure prophylaxis$335,239
U01 · FY2004 · AI
Human Mab cocktail for rabies post-exposure prophylaxis$163,688
U01 · FY2003 · AI